newsfilter
← Latest News
GlobeNewswire·

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory